ArticleFlavour EnhancersSee how the patent activity of flavour enhancers has changed over time.United KingdomIntellectual PropertyCipher
ArticleIP Ingredients Blog, Parts 1-9Welcome to our new blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink sector.United KingdomIntellectual PropertyHGF Law
ArticleIP Ingredients Blog, Parts 11-20Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink sector.United KingdomIntellectual PropertyHGF Law
ArticleJ A Kemp Ranked As One Of Europe's Leading Patent Law Firms 2020 By Financial TimesThe Financial Times has revealed the results of its 2020 survey of Europe's patent law firms. This listing is based on recommendations by clients and peers, as compiled by the FT's research partnerUnited KingdomIntellectual PropertyJ A Kemp
ArticlePatenting Biological Simulations In Drug DiscoveryOur article ‘Patenting Biological Simulations in Drug Discovery' has been published in Drug Discovery Today, by Elsevier. It examines the challenges faced when pursuing patent protection...United KingdomIntellectual PropertyGill Jennings & Every
ArticlePrecision Medicine Patenting Of Known Drugs For Known Indications At The EPO (Video)The identification of specific sub-groups of patients to treat with a known drug, even if said patients may have been treated before with the drug...United KingdomIntellectual PropertyHGF Law
ArticleTackling The Source Of Phantom Limb Pain With Nerve StimulationMillions of people worldwide suffer from pain that is perceived to be in an area of the body that is paradoxically no longer (or never was) attached to the body.United KingdomIntellectual PropertyMarks & Clerk
ArticleUK Approach To Plausibility Remains Unchanged Despite EPO's G2/21In the recent decision Generics v AstraZeneca, the UK Court of Appeal confirmed that the UK's approach to ‘plausibility' remains unchanged despite the EPO Enlarged Board of Appeal decision G2/21. United KingdomIntellectual PropertyPotter Clarkson LLP
ArticleSobering Action: Immediate Ban For Irresponsible Drinking AdThe ASA has taken the "unusual step" of immediately removing an ad by a company called Koosday for a club night.United KingdomMedia, Telecoms, IT, EntertainmentReed Smith (Worldwide)
ArticleAgriculture News UpdateThe introduction of a new Groceries Code adjudicator took an important step forward when the Bill was introduced into Parliament in May.United KingdomStrategySmith & Williamson
ArticleThis Week In 340B: February 21 – 27, 2023This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country.United KingdomFood, Drugs, Healthcare, Life SciencesMcDermott Will & Emery
ArticleJuly 2018 Update: Key Developments In UK And EU Environment, Safety And Health Law, Procedure And PolicyWe are pleased to share with you the latest edition of "frESH Law Horizons: Key Developments in UK & EU Environment, Safety and Health Law ...European UnionEmployment and HRSquire Patton Boggs LLP
ArticleBPR Challenged For The First Time Before The Court Of JusticeThe Court of Justice of the EU delivered a judgment in which the Biocidal Product Regulation 528/2012 (''BPR'') was challenged for the first time.European UnionFood, Drugs, Healthcare, Life SciencesFieldfisher
ArticleEuropean Commission Adopts Implementing Acts For Regulation (EU) 2015/2283 On Novel FoodsOn December 20, 2017, the European Commission adopted three Implementing Regulations to Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods ...European UnionFood, Drugs, Healthcare, Life SciencesJones Day
ArticleEuropean Commission Renews Approval Of GlyphosateOn December 12, 2017, the European Commission adopted Implementing Regulation (EU) 2017/2324 renewing the approval of the active substance glyphosate in accordance with Regulation ...European UnionFood, Drugs, Healthcare, Life SciencesJones Day
ArticleSynapse - Law For Life Sciences: Latest News - January 2016Accord Healthcare & Anor v Astellas Pharma GmbH & Anor [2015] EWHC 3676 (Ch) is an unusual decision in that it concerns only declaratory relief rather than any claim to damages. European UnionFood, Drugs, Healthcare, Life SciencesTaylor Wessing
ArticleUK Food Products Gain Protected Status In JapanA host of UK food and drink products have gained protected status in Japan. Businesses have welcomed the news that 37 Geographical Indications (GIs) for UK food and drink...GlobalFood, Drugs, Healthcare, Life SciencesMarks & Clerk
ArticleCAT Rules In Favour Of NHS In Significant Competition Claim Against PharmaceuticalsPeters & Peters successfully defended the NHS in litigation against Lundbeck and others, securing a ruling that the NHS's claim over inflated prescription costs for citalopram due to 'pay for delay' agreements was filed within the correct two-year limitation period, allowing the case to proceed.United KingdomAntitrust/Competition LawPeters & Peters Solicitors LLP
ArticleECHA publishes a Practical Guide on the Biocidal Products RegulationThe first official Article 95 list of relevant substances, and respective substance and product suppliers in the EU was published by the European Chemical Agency (ECHA) on 24 September 2014.United KingdomAntitrust/Competition LawFieldfisher
ArticleThe UK's Doomed Medical Cannabis (Access) BillBCL Senior Associate, David Hardstaff and Partner, John Binns write for Open Access Government exploring the UK's doomed Medical Cannabis Bill.United KingdomCannabis & HempBCL Solicitors LLP